Seer (SEER) Stock Faces Revenue Slump As Losses Stay Heavy

Seer came into this earnings print as a high‑expectation growth stock in proteomics, with the share price up over the past quarter and trading on a rich P/S multiple. The immediate reaction was muted, with the stock slipping about 2% to US$2.10. That small move sits against a quarter that again showed modest revenue of US$3.1 million and a net loss of US$16.9 million, while cash and investments held at US$209.5 million.

The key focus for Seer this quarter is the ongoing profitability strain. The market is still paying a premium for the potential benefits of scale, even as losses continue to weigh on the income statement.

Is Seer’s rich 8.2x P/S multiple a justified premium for its forecast 26.2% revenue growth, or does ongoing unprofitability point to valuation risk instead? Compare the assumptions driving that gap in our valuation analysis for Seer

Q2 2026 Earnings Summary

• Revenue (Q2 2026 vs. Q2 2025): US$3.10 million vs. US$4.05 million (revenue declined 23.4%)
• Net Loss (Q2 2026 vs. Q2 2025): US$16.90 million vs. US$19.42 million (net loss narrowed 13.0%)
• Basic EPS (Q2 2026 vs. Q2 2025): loss of US$0.31 per share vs. loss of US$0.33 per share (per share loss narrowed 8.4%)
• Gross Margin (Q2 2026 vs. Q2 2025): 49% vs. 52% (margin declined 3 percentage points)

Prefer clear visuals instead of scrolling through more earnings text and raw figures? See Seer’s full financial picture with an at a glance view of its valuation in our company report for Seer.

Seer bull case leans on proof of adoption

Bulls argue that Seer’s Proteograph platform, growing publication base and Thermo Fisher partnership are laying the groundwork for durable adoption and higher margin consumable revenue. The latest quarter offers partial support. Publications grew to more than 95, which management framed as roughly 80% growth year over year, and Roche plus a Nature Genetics head to head study backed the technology’s depth and reproducibility. Sequential revenue moved from US$2.8 million in Q1 to US$3.1 million in Q2, helped by consumable pull through and STAC service revenue. Management also pointed to early signs from the revamped sales team, including direct engagement with about 20% of North American customers and new SIP placements. However, with full year 2026 guidance only implying low single digit growth and gross margin at 49%, the shift to a richer consumable mix and higher profitability is still more promise than delivered milestone.

Seer bear case focuses on growth, burn and noise

The bearish story centers on weak top line momentum, heavy cash burn and governance noise that could distract from execution. Q2 revenue of US$3.1 million declined 23.4% year over year, and gross margin slipped from 52% to 49%, which works against the idea of near term operating leverage. Net loss remained large at US$16.9 million and free cash flow for the first half was negative about US$25.3 million, even with some cost discipline and lower stock based compensation. Management reaffirmed 2026 revenue guidance of US$16 million to US$18 million, which implies only modest growth versus 2025, while also saying academic and government funding headwinds are likely to persist through 2026. On top of that, an ongoing activist campaign and a CEO led take private proposal keep governance uncertainty high. The small share price decline after results suggests no clear relief from these concerns yet.

After a quarter with revenue pressure, a large ongoing loss and active governance disputes, you may want to review whether these issues hint at deeper structural problems or just short term noise. Scan our risk analysis for Seer which shows 2 important warning signs

Stay Ahead With Seer Insights

If Seer’s rich P/S multiple, revenue pressure and ongoing losses have your attention, register for free with Simply Wall St and add it to a Watchlist so you can track price against fair value and wait for a setup that fits your strategy. After you decide to take a position, keep on top of only the most important developments with the Portfolio Command Center that helps filter out market noise and surface the updates that really matter. For a longer term view, tap into the crowd’s thinking and compare your thesis on Seer with thousands of others through the Community. This way you can spot potential catalysts or emerging risks early and stay a step ahead of the market.

Seeking Alternatives Beyond Seer Right Now

Fresh stock stories can start to break out before the crowd even looks. Momentum shifts, prices move, and the best entry points get caught quickly, so act now.

• Spot companies quietly building strength before momentum headlines hit by scanning the curated 18 high quality undiscovered gems that are still under the radar for now.
• Target resilient potential compounders with clean finances by working through a filtered list of solid balance sheet and fundamentals stocks (49 results) instead of sifting through hundreds of weaker balance sheets.
• Ride long term infrastructure themes while they are still forming by tracking opportunities across a focused 35 power grid technology and infrastructure stocks that many investors are not watching yet.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com